We’re Not a Diagnostics Company
EazeBio is a digital health and biological intelligence platform.
Instead of one-time snapshots, we focus on biological changing patterns and trends — the signals that matter before disease ever shows up.
Turning biomarkers into breakthrough diagnostics and care pathways - starting with metabolic conditions.
Instead of one-time snapshots, we focus on biological changing patterns and trends — the signals that matter before disease ever shows up.
Simple at-home tests, guided by our app.
For clinicians and partners, EazeBio supports professional workflows.
We support multiple sensing methods — from lateral flow tests to advanced immunoassays — depending on where and how care delivers.
Our digital layer turns raw results into meaningful, human-readable insight — focused on trend, not alarm
Your biology isn’t static. We help you see patterns over weeks and months, not just one moment in time.
In parallel, we are developing next-generation cortisol sensing technology based on advanced biosensing IP we have acquired and are co-developing with leading academic partners.
This work is focused on real-time stress biology and reflects where the platform is going — not just where it is today.
Healthcare is shifting toward:
EazeBio is built for this future — empowering individuals and supporting clinicians with the same biological foundation.
Strategic partnership to advance and commercialize a groundbreaking instrument-free diagnostic platform…
Learn More
Finalist for ALFC 2025 Innovation Award — breakthrough science redefining healthcare…
Learn More
Dubai is a true crossroads for innovation, investment, and global collaboration…
Learn More
"EazeBio is also developing next-generation biosensing technologies to support a deeper, longitudinal understanding of stress biology."
Consumer offerings are wellness screening tools and are not intended to diagnose or treat disease.
Professional workflows are designed for clinical and laboratory environments.
